Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data ...

Amplify Energy Corp. ('Amplify” or the 'Company”) (NYSE: AMPY) announced today that the Company will be participating in the ...

Vornado Realty Trust (NYSE:VNO) announced today that it has completed a $120 million refinancing of 4 Union Square South, a 204,000 square foot Manhattan retail property. The ten-year interest only ...

Los Angeles, CA, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping our future, today announced Maximus is No. 27 on the ...

Antalpha Platform Holding Company (NASDAQ: ANTA) ('Antalpha' or the 'Company'), a leading institutional digital asset financing platform, today announced its unaudited financial results for the second ...

Okeanis Eco Tankers Corp. ('OET” or the 'Company”) (NYSE: ECO / OSE: OET) announced today that the Company's board of directors (the 'Board”) has declared a dividend on its common shares (the ...

What should out-of-state buyers know before purchasing property in Wilmington, North Carolina? According to Scott Saxton, ...

In June 2025, Fractyl presented preclinical data at the American Diabetes Association’s 85th Scientific Sessions that showed ...

Duchenne (SGT-003): 15 participants dosed in the Phase 1/2 INSPIRE DUCHENNE trial and dosing remains ongoing; On track to ...

How many distilleries should you visit each day on Kentucky’s Bourbon Trail? According to Victoria and Josh Hoff of WhiskMe ...

The USAN Council has adopted zervimesine as the United States Adopted Name (USAN) for CT1812.

Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary ...